Airain Ltd’s Quest Diagnostics DGX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2017
Q2
$1.62M Buy
14,539
+9,422
+184% +$996K 0.07% 309
2017
Q1
$502K Buy
+5,117
New +$488K 0.02% 496
2016
Q2
Sell
-11,064
Closed -$791K 711
2016
Q1
$791K Buy
+11,064
New +$742K 0.05% 339
2015
Q4
Sell
-30,419
Closed -$1.87M 885
2015
Q3
$1.87M Buy
30,419
+24,958
+457% +$1.74M 0.11% 241
2015
Q2
$396K Buy
+5,461
New +$403K 0.02% 581
2014
Q2
Sell
-37,952
Closed -$2.2M 797
2014
Q1
$2.2M Buy
37,952
+21,359
+129% +$1.14M 0.39% 57
2013
Q4
$888K Buy
16,593
+10,593
+177% +$628K 0.12% 200
2013
Q3
$371K Sell
6,000
-3,696
-38% -$221K 0.07% 293
2013
Q2
$588K Buy
+9,696
New +$578K 0.09% 241

Other funds holding DGX

Airain Ltd's DGX Position: Q2 2017 in Review

Airain Ltd increased its Quest Diagnostics (DGX) stake by 184% in Q2 2017, buying an estimated $996K and bringing the position to 14,539 shares worth $1.62M. The position accounts for 0.07% of the portfolio, ranked #309.

Airain Ltd first reported a position in DGX in Q2 2013 and has held it in 9 quarters since. The position peaked at $2.2M in Q1 2014. 643 funds tracked by Wall St. Rank hold DGX as of Q2 2017.

  • Airain Ltd held 14,539 shares of Quest Diagnostics worth $1.62M as of Q2 2017.
  • Airain Ltd bought 9,422 Quest Diagnostics shares in Q2 2017, an estimated $996K.
  • Quest Diagnostics made up 0.07% of Airain Ltd's portfolio in Q2 2017, its #309 holding.
  • Airain Ltd first reported a position in Quest Diagnostics in Q2 2013 and has held it in 9 quarters since.
  • Airain Ltd's Quest Diagnostics position peaked at $2.2M in Q1 2014.
  • 643 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2017.

Based on Airain Ltd's 13F filing for Q2 2017, filed 8 Aug 2017.